W9- Health impact Fund Pogge

Question 1

10/90 problem

Answer 1

according to Poggee- only 10% of pharmaceutical R & D are focused on diseases that account for 90% of the global burden of disease 90% of world’s resources are attached to diseases that effect 10% of the worlds population

Question 2

Negative Duties

Answer 2

• duties not to harm another individual – to not harm others by being complicit in or benefiting from an unjust global order that causes massive human rights deficits in terms of serve poverty and poverty related death / suffering
• Elects to focus on cases where human rights are violated due to a failure to uphold negative duties–> Duties not to harm another individual

Question 3

globalized monopoly patent regime

Answer 3

drug patents as incentives to do expensive drug research

Question 4

Last-mile problem

Answer 4

getting the poor access, but also ensuring that the poor actually benefit from the medicines they need

Question 5

Effective global public health

Answer 5

poor countries become super-lucrative markets, and poor are no longer systematically denied access

Question 6

Pogge solution to problem in poor countries

Answer 6

• Implement the HIF (Health Impact Fund) to ensure poor countries have access to drugs for common diseases in these poor countries
• registered innovator would have incentives to ensure that patients are fully instructed and properly provisioned so that they make optimal use (dosage, compliance, etc.) of its medicines, which will then, through wide and effective deployment, have their optimal public health impact

Question 7

The problem with testing on poor

Answer 7

-The poor are often obligated by dire need or debt to incur additional health risks, by selling a kidney… they lack [resources, power, have weak agency and information deficits,] face worse odds for recovering from disease… all these factors ensure that the [global] poor bear a hugely disproportional burden of disease

Question 8

Drug companies motivation

Answer 8

profit maximisation

Question 9

Problem of monopolies

Answer 9

• Sky high, profit-maximizing prices
• Bias towards symptom relief, rather than cure/prevention (e.g. vaccinations) if they cure the disease they wont get patients coming back for more treatments not getting more money.

Question 10

HIF

Answer 10

-Motivate drug companies do the most they can to contribute to lowering global disease burden by improving the health systems in poorer countries
Drugs/companies get rewards proportional to the amount they actually lower the global burden of disease

Question 11

HIF problems solved

Answer 11

Access problem 
Availability problem 
Bias towards symptom relief 
Wasted resources on patent-related litigation 
Counterfeiting 
Excessive (wasteful)marketing 
Last-mile problem

Question 12

Funding HIF

Answer 12

where will the money come from? who will pay what?

Question 13

Determination of reward formular/ how to measure BOD

Answer 13

how to measure the DALYS? how many $ per DALYS

Question 14

Reduction from drug

Answer 14

how to determine it was the drug not another factor that reduced the BOD?